1. Home
  2. TELA vs RAND Comparison

TELA vs RAND Comparison

Compare TELA & RAND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TELA
  • RAND
  • Stock Information
  • Founded
  • TELA 2012
  • RAND 1969
  • Country
  • TELA United States
  • RAND United States
  • Employees
  • TELA 209
  • RAND N/A
  • Industry
  • TELA Medical/Dental Instruments
  • RAND Finance: Consumer Services
  • Sector
  • TELA Health Care
  • RAND Finance
  • Exchange
  • TELA Nasdaq
  • RAND Nasdaq
  • Market Cap
  • TELA 62.6M
  • RAND 54.4M
  • IPO Year
  • TELA 2019
  • RAND N/A
  • Fundamental
  • Price
  • TELA $1.51
  • RAND $15.21
  • Analyst Decision
  • TELA Buy
  • RAND
  • Analyst Count
  • TELA 3
  • RAND 0
  • Target Price
  • TELA $5.33
  • RAND N/A
  • AVG Volume (30 Days)
  • TELA 74.6K
  • RAND 5.0K
  • Earning Date
  • TELA 11-06-2025
  • RAND 11-05-2025
  • Dividend Yield
  • TELA N/A
  • RAND 11.03%
  • EPS Growth
  • TELA N/A
  • RAND N/A
  • EPS
  • TELA N/A
  • RAND N/A
  • Revenue
  • TELA $75,323,000.00
  • RAND $7,966,118.00
  • Revenue This Year
  • TELA $25.72
  • RAND N/A
  • Revenue Next Year
  • TELA $22.03
  • RAND N/A
  • P/E Ratio
  • TELA N/A
  • RAND N/A
  • Revenue Growth
  • TELA 16.34
  • RAND 1.16
  • 52 Week Low
  • TELA $0.86
  • RAND $13.82
  • 52 Week High
  • TELA $3.26
  • RAND $31.89
  • Technical
  • Relative Strength Index (RSI)
  • TELA 37.37
  • RAND 46.04
  • Support Level
  • TELA $1.53
  • RAND $14.50
  • Resistance Level
  • TELA $1.73
  • RAND $15.25
  • Average True Range (ATR)
  • TELA 0.15
  • RAND 0.66
  • MACD
  • TELA -0.01
  • RAND 0.03
  • Stochastic Oscillator
  • TELA 0.00
  • RAND 31.70

About TELA TELA Bio Inc.

TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.

About RAND Rand Capital Corporation

Rand Capital Corp is a closed-end, externally managed, non-diversified investment company. The company's investment objective is to generate current income and, when possible, complement its current income with capital appreciation by focusing its debt and related equity investments in privately-held, lower middle market companies with committed and experienced managements in a broad variety of industries. It predominantly invests in higher-yielding debt instruments.

Share on Social Networks: